IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

IDEXX provides diagnostic and software products and services for pet healthcare, self-described as a global leader in veterinary innovation.

IDEXX

IDEXX Animana

ezyVet

IDEXX Small Animal Health

IDEXX Water Testing

Livestock Diagnostics

10,000 people, one global focus﻿ - enhancing the health and well-being of pets, people, and livestockWe are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	1.49B -	1.60B 7.81%	1.78B 10.83%	1.97B 10.91%	2.21B 12.40%	2.41B 8.75%	2.71B 12.45%	3.22B 18.79%	3.37B 4.73%	3.66B 8.72%
cost of revenue	669.69M -	711.62M 6.26%	799.99M 12.42%	871.68M 8.96%	971.70M 11.47%	1.04B 7.17%	1.14B 9.05%	1.33B 16.76%	1.36B 2.79%	1.47B 7.92%
gross profit	816.12M -	890.27M 9.09%	975.44M 9.57%	1.10B 12.50%	1.24B 13.14%	1.37B 9.99%	1.57B 15.05%	1.89B 20.27%	2.00B 6.08%	2.19B 9.26%
selling and marketing expenses	283.71M -	299.95M 5.73%	317.06M 5.70%	354.29M 11.74%	387.41M 9.35%	418.19M 7.95%	434.44M 3.88%	486.74M 12.04%	524.50M 7.76%	566.07M 7.92%
general and administrative expenses	173.89M -	182.51M 4.96%	207.02M 13.43%	220.88M 6.70%	244.94M 10.89%	261.32M 6.69%	300.83M 15.12%	309.66M 2.93%	326.25M 5.36%	335.82M 2.94%
selling general and administrative expenses	457.60M -	482.46M 5.43%	524.08M 8.62%	575.17M 9.75%	632.34M 9.94%	679.51M 7.46%	735.27M 8.21%	796.39M 8.31%	850.75M 6.83%	901.89M 6.01%
research and development expenses	98.26M -	99.68M 1.44%	101.12M 1.45%	109.18M 7.97%	117.86M 7.95%	133.19M 13.01%	141.25M 6.05%	161.01M 13.99%	254.82M 58.26%	190.95M 25.06%
other expenses
cost and expenses	1.23B -	1.29B 5.57%	1.43B 10.16%	1.56B 9.18%	1.72B 10.66%	1.85B 7.67%	2.01B 8.53%	2.28B 13.48%	2.47B 8.11%	2.56B 3.86%
operating expenses	555.86M -	582.15M 4.73%	625.20M 7.40%	684.35M 9.46%	750.21M 9.62%	812.70M 8.33%	876.52M 7.85%	957.40M 9.23%	1.11B 15.48%	1.09B 1.15%
interest expense	13.70M -	26.77M 95.41%	28.39M 6.06%	31.97M 12.60%	33.59M 5.07%	30.63M 8.83%	32.54M 6.24%	29.37M 9.73%	38.79M 32.07%	-35.95M 192.68%
ebitda	260.25M -	308.12M 18.39%	350.24M 13.67%	413.03M 17.93%	491.33M 18.96%	552.85M 12.52%	694.52M 25.63%	932.03M 34.20%	898.76M 3.57%	1.10B 22.07%
operating income	260.25M -	299.91M 15.24%	350.24M 16.78%	413.03M 17.93%	491.33M 18.96%	552.85M 12.52%	694.52M 25.63%	932.03M 34.20%	898.76M 3.57%	1.10B 22.07%
depreciation and amortization	58.89M -	68.96M 17.10%	78.22M 13.43%	83.14M 6.29%	83.18M 0.05%	88.01M 5.81%	96.00M 9.08%	104.60M 8.96%	111.90M 6.98%
total other income expenses net	-13.70M -	-8.21M 40.06%	-28.39M 245.75%	-31.97M 12.60%	-33.59M 5.07%	-30.63M 8.83%	-32.54M 6.24%	-29.37M 9.73%	-38.79M 32.07%	-35.95M 7.32%
income before tax	246.56M -	273.14M 10.78%	321.85M 17.83%	381.06M 18.40%	457.74M 20.12%	522.22M 14.09%	661.99M 26.76%	902.65M 36.36%	859.97M 4.73%	1.06B 23.40%
income tax expense	64.60M -	81.01M 25.39%	99.79M 23.19%	117.79M 18.03%	80.69M 31.49%	94.43M 17.02%	79.85M 15.43%	157.81M 97.62%	180.88M 14.62%	216.13M 19.49%
net income	181.91M -	192.08M 5.59%	222.04M 15.60%	263.14M 18.51%	377.03M 43.28%	427.72M 13.44%	581.78M 36.02%	744.85M 28.03%	679.09M 8.83%	845.04M 24.44%
weighted average shs out	100.09M -	92.60M 7.49%	89.73M 3.10%	87.77M 2.19%	86.86M 1.03%	86.11M 0.86%	85.34M 0.90%	85.20M 0.17%	83.62M 1.85%	83.07M 0.67%
weighted average shs out dil	101.50M -	93.65M 7.74%	90.88M 2.95%	89.57M 1.45%	88.47M 1.22%	87.54M 1.05%	86.72M 0.94%	86.57M 0.17%	84.60M 2.28%	83.98M 0.74%
eps	1.82 -	2.07 13.74%	2.47 19.32%	3 21.46%	4.34 44.67%	4.97 14.52%	6.82 37.22%	8.74 28.15%	8.12 7.09%	10.17 25.28%
epsdiluted	1.79 -	2.05 14.53%	2.44 19.02%	2.94 20.49%	4.26 44.90%	4.89 14.79%	6.71 37.22%	8.60 28.17%	8.03 6.63%	10.06 25.28%

NASDAQ:IDXX

IDEXX

Last Close

418.55

22/11 21:00

Market Cap

39.92B

Beta: 1.19

Volume Today

487.13K

Avg: 394.50K

PE Ratio

57.52

PFCF: 68.57

Preview